Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy KEFI Gold and Copper (KEFI) by Hot Stock Rockets in ShareProphets
- Hold Lloyds Banking Group (LLOY) by Alan Oscroft in The Motley Fool
- Buy Xaar (XAR) by Berenberg
- Sell Corero Network Security (CNS) by Steve Moore in ShareProphets
- Sell Everyman Media Group (EMAN) by Steve Moore in ShareProphets
- Hold BP (BP.) by Tom Winnifrith in ShareProphets
- Hold BP (BP.) by Steve Moore in ShareProphets
- Buy Fresnillo (FRES) by Citi
- Buy RM (RM.) by Steve Moore in ShareProphets
- Buy Capital Limited (DI) (CAPD) by Steve Moore in ShareProphets
- Hold JD Sports Fashion (JD.) by Mark Hartley in The Motley Fool
- Speculative Buy Kodal Minerals (KOD) by Canaccord Genuity
- Buy Renew Holdings (RNWH) by Peel Hunt
- Sell Crimson Tide (TIDE) by Steve Moore in ShareProphets
- Hold Glencore (GLEN) by Harvey Jones in The Motley Fool
- Hold Burberry Group (BRBY) by Harvey Jones in The Motley Fool
- Add Aviva (AV.) by Andrew Mackie in The Motley Fool
- Hold Lloyds Banking Group (LLOY) by Dr. James Fox in The Motley Fool
- Hold BP (BP.) by Harvey Jones in The Motley Fool
- Hold Lloyds Banking Group (LLOY) by Alan Oscroft in The Motley Fool
Allergy Therapeutics (AGY) Share Price
Health Care Sector
NOTE: This is based on 23 open tips for Allergy Therapeutics (AGY)
| Latest Bid : 10.50p | Latest Ask : 11.50p |
| High Today : 11.70p | Low Today : 11.00p |
| This Years High : 11.80p | This Years Low : 5.25p |
| Volume : 39,783 | MKT Cap : £548.09M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Allergy Therapeutics (AGY) Overview
We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments. We believe that transformational outcomes for patients are achieved by directly treating the cause, rather than just managing symptoms. Our vaccines are aluminium free. Driving convenience; our ultra-short course treatments make life easier and increase adherence.Allergy Therapeutics (AGY) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Steve Moore | Premium Only | 2024-08-27 14:40:00 27/08/2024 | -187.50% |
| Avoid | Steve Moore | Premium Only | 2024-02-14 13:40:00 14/02/2024 | -400.00% |
| Avoid | Steve Moore | Premium Only | 2023-08-10 11:35:00 10/08/2023 | -379.17% |
| Avoid | Steve Moore | Premium Only | 2022-12-29 10:45:00 29/12/2022 | -182.50% |
| Avoid | Steve Moore | Premium Only | 2022-07-15 16:05:00 15/07/2022 | 50.00% |
Allergy Therapeutics (AGY) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 10.50p | Latest Ask : 11.50p |
| High Today : 11.70p | Low Today : 11.00p |
| This Years High : 11.80p | This Years Low : 5.25p |
| Volume : 39,783 | MKT Cap : £548.09M |
Allergy Therapeutics Overview
We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments. We believe that transformational outcomes for patients are achieved by directly treating the cause, rather than just managing symptoms. Our vaccines are aluminium free. Driving convenience; our ultra-short course treatments make life easier and increase adherence.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Allergy Therapeutics Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Steve Moore | Premium Only | 2024-08-27 14:40:00 27/08/2024 | -187.50% |
| Avoid | Steve Moore | Premium Only | 2024-02-14 13:40:00 14/02/2024 | -400.00% |
| Avoid | Steve Moore | Premium Only | 2023-08-10 11:35:00 10/08/2023 | -379.17% |
| Avoid | Steve Moore | Premium Only | 2022-12-29 10:45:00 29/12/2022 | -182.50% |
| Avoid | Steve Moore | Premium Only | 2022-07-15 16:05:00 15/07/2022 | 50.00% |